Meso Scale Discovery has released its S-PLEX immunoassay platform, which, the company said, is 1,000 times more sensitive than existing ELISA technologies and can detect analytes at concentrations below 1 femtogram per mL.
Biotech firm BioScale presented data this week at the Society of Laboratory Automation and Screening annual meeting in Orlando demonstrating the ability of its acoustic membrane microparticle technology to quantify levels of multiple cytokines in serum and plasma.
The California Institute of Technology of Pasadena has received US Patent No. 8,354,231, "Methods and systems for detecting and/or sorting targets." The methods provided are based on the combined use of polynucleotide-encoded protein and substrate polynucleotides.
NEW YORK (GenomeWeb News) – Mark Boguski, a faculty member at the Harvard Medical School and Beth Israel Deaconess Medical Center, has co-founded a new consulting company called Genome Health Solutions.
By Molika Ashford
Bioscale this week presented data on the application of its acoustics-based protein detection technology to measure and quantitate the activity state of multiple kinases in the MAPK pathway.
Vermillion announced this week that Sandra Gardiner has resigned as vice president and chief financial officer and is leaving the company to take a job with an undisclosed firm in the San Francisco Bay Area.
The drugmaker, which purchased a system in August after several months of trying out a beta version, is using it to measure pharmacodynamic biomarkers, and has found it cuts run times for such assays from a week down to as little as a day.